Search Results

Search Results for "diabetes"

• EU Doctors urge caution when prescribing Lipitor
  Some European medical professionals are urging their colleagues to use caution in prescribing the class of cholesterol-lowering drugs known as statins, following reports linking the medications to a higher risk of diabetes. In a study published in the British Medical Journal, Canadian researchers sa...

• Research shows promise for distinguishing pancreas ailments
  Mayo Clinic researchers say they’ve uncovered “promising” findings for a method designed to distinguish between pancreatitis and pancreatic cancer. According to a report on News-Medical.Net, the two conditions can be difficult to tell apart. Cancer that affects the pancreas is a particularly d...

• Writer’s reluctance to take Lipitor led to effective diet
  In an interview with the Huffington Post, New York Times food writer Mark Bittman discusses his new diet plan that consists of eating vegan, or eating no animal products, before 6 p.m. every day. Bittman has recently published a book on his diet called VB6: Eat Vegan Before 6:00 to Lose Weight and R...

• Diet and exercise program helps diabetics
  A study from the U.S. Centers for Disease Control and Prevention found that one in nine people with diabetes saw their blood sugar levels drop down to normal or “pre-diabetes” levels after participating in an intensive, year-long diet and exercise program, Reuters reports. Although complete remi...

• Liptruzet cholesterol medication’s approval is controversial
  In a piece for Forbes, writer John LaMattina takes issue with Merck’s attempts to get the LDL cholesterol lowering drug, Liptruzet, approved and on the market. He also finds fault with the U.S. Food and Drug Administration for approving it in the first place. LaMattina writes that Liptruzet is rea...

• Januvia “red flags” cited by investors
  In a video posted on investing Website Motley Fool, contributing writer Max Chatsko says there are a couple of “red flags” investors should be aware of regarding Merck’s bestselling Januvia/Janumet franchise for treating type 2 diabetes. Revenue from that franchise fell 2 percent in the first ...

• Study says blood test promising for pancreatic cancer
  Japanese researchers are optimistic about the results of a study suggesting that a new blood test designed to detect pancreatic cancer early may improve patients’ odds for survival. A HealthDay News story says the improved odds are relatively small. But given the nature of pancreatic cancer, any p...

• FDA panel votes to reduce Avandia restrictions
  A U.S. Food and Drug Administration panel has recommended allowing the diabetes drug Avandia to remain on the market with relaxed restrictions on its use, according to NBC News. The story says Avandia was once the world’s top-selling diabetes drug. But in 2007, an analysis of other studies suggest...

• Company pleads guilty to drug safety violations
  Ranbaxy, a subsidiary of Japanese pharmaceutical company Daiichi Sankyo, has pleaded guilty to drug safety violations. According to a story in the New York Times, the company will pay $500 million in fines over allegations that it sold subpar drugs. Company officials also allegedly made false statem...

• Report: Byetta, Januvia, makers downplayed risk of pancreatic cancer
  The prestigious medical journal BMJ has published a damning investigative article on a crop of new diabetes drugs called “incretin therapies,” which include Byetta and Januvia. The article mentions a number of studies that have been published in recent years, indicating a potential link between ...